After three decades of antiretroviral therapy, HIV has changed from being a lethal disease to a chronic condition, mostly due to drastic improvements in antiretrovirals (ARVs). In a constant evolving field, understanding the drug interactions, the clinical pharmacology and having up-to-date information on clinical practices is essential for designing optimal treatment strategies leading to better treatment outcomes.
Excellence in ARV treatment has a direct impact on the efficacy and tolerability obtained in the quality of life of HIV-infected subjects and the cost-efficacy of treatment budgets in the HIV disease. As information evolves quickly, timely updates of the topics with clinical impact on antiretroviral treatment strategies and drug choice are a must.
On the other hand, we are moving towards the elimination of HIV transmission, prevention strategies are now available such as Pre-exposure Prophylaxis (PrEP) which is a hot topic of overwhelming interest that will be addressed in this workshop and long-acting ARTs.
Join the 5th edition of the HIV Clinical Topics and learn more about the latest practices in the field of antiretroviral treatment from a theoretical, practical, and interactive perspective.